nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—CYP3A4—Fingolimod—multiple sclerosis	0.075	0.139	CbGbCtD
Modafinil—CYP2C19—Prednisone—multiple sclerosis	0.0606	0.112	CbGbCtD
Modafinil—CYP2B6—Dexamethasone—multiple sclerosis	0.0595	0.11	CbGbCtD
Modafinil—CYP3A4—Methylprednisolone—multiple sclerosis	0.0483	0.0893	CbGbCtD
Modafinil—CYP3A5—Dexamethasone—multiple sclerosis	0.0469	0.0866	CbGbCtD
Modafinil—CYP2C19—Dexamethasone—multiple sclerosis	0.0378	0.0698	CbGbCtD
Modafinil—CYP3A4—Triamcinolone—multiple sclerosis	0.0366	0.0677	CbGbCtD
Modafinil—CYP3A4—Mitoxantrone—multiple sclerosis	0.0353	0.0651	CbGbCtD
Modafinil—CYP2C9—Dexamethasone—multiple sclerosis	0.0314	0.0581	CbGbCtD
Modafinil—CYP3A4—Betamethasone—multiple sclerosis	0.0314	0.058	CbGbCtD
Modafinil—CYP3A4—Prednisolone—multiple sclerosis	0.031	0.0573	CbGbCtD
Modafinil—CYP3A4—Prednisone—multiple sclerosis	0.0293	0.0541	CbGbCtD
Modafinil—CYP3A4—Dexamethasone—multiple sclerosis	0.0183	0.0338	CbGbCtD
Modafinil—Fosphenytoin—ALB—multiple sclerosis	0.000353	0.214	CrCbGaD
Modafinil—Haematuria—Methotrexate—multiple sclerosis	0.000326	0.000791	CcSEcCtD
Modafinil—Shock—Triamcinolone—multiple sclerosis	0.000325	0.000789	CcSEcCtD
Modafinil—Insomnia—Prednisolone—multiple sclerosis	0.000325	0.000788	CcSEcCtD
Modafinil—Shock—Methylprednisolone—multiple sclerosis	0.000325	0.000787	CcSEcCtD
Modafinil—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000324	0.000784	CcSEcCtD
Modafinil—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000323	0.000783	CcSEcCtD
Modafinil—Loss of consciousness—Betamethasone—multiple sclerosis	0.000323	0.000783	CcSEcCtD
Modafinil—Epistaxis—Methotrexate—multiple sclerosis	0.000323	0.000783	CcSEcCtD
Modafinil—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000323	0.000783	CcSEcCtD
Modafinil—Paraesthesia—Prednisolone—multiple sclerosis	0.000323	0.000783	CcSEcCtD
Modafinil—Tachycardia—Triamcinolone—multiple sclerosis	0.000323	0.000782	CcSEcCtD
Modafinil—Mental disorder—Prednisone—multiple sclerosis	0.000322	0.000781	CcSEcCtD
Modafinil—Nausea—Azathioprine—multiple sclerosis	0.000322	0.000781	CcSEcCtD
Modafinil—Tachycardia—Methylprednisolone—multiple sclerosis	0.000322	0.000781	CcSEcCtD
Modafinil—Skin disorder—Methylprednisolone—multiple sclerosis	0.00032	0.000777	CcSEcCtD
Modafinil—Malnutrition—Prednisone—multiple sclerosis	0.00032	0.000776	CcSEcCtD
Modafinil—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00032	0.000775	CcSEcCtD
Modafinil—Agranulocytosis—Methotrexate—multiple sclerosis	0.000319	0.000775	CcSEcCtD
Modafinil—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000319	0.000773	CcSEcCtD
Modafinil—Convulsion—Dexamethasone—multiple sclerosis	0.000318	0.000772	CcSEcCtD
Modafinil—Convulsion—Betamethasone—multiple sclerosis	0.000318	0.000772	CcSEcCtD
Modafinil—Hypertension—Betamethasone—multiple sclerosis	0.000317	0.000769	CcSEcCtD
Modafinil—Hypertension—Dexamethasone—multiple sclerosis	0.000317	0.000769	CcSEcCtD
Modafinil—Asthenia—Mitoxantrone—multiple sclerosis	0.000314	0.000762	CcSEcCtD
Modafinil—Myalgia—Dexamethasone—multiple sclerosis	0.000313	0.000759	CcSEcCtD
Modafinil—Myalgia—Betamethasone—multiple sclerosis	0.000313	0.000759	CcSEcCtD
Modafinil—Anxiety—Dexamethasone—multiple sclerosis	0.000312	0.000756	CcSEcCtD
Modafinil—Anxiety—Betamethasone—multiple sclerosis	0.000312	0.000756	CcSEcCtD
Modafinil—Discomfort—Betamethasone—multiple sclerosis	0.000309	0.00075	CcSEcCtD
Modafinil—Discomfort—Dexamethasone—multiple sclerosis	0.000309	0.00075	CcSEcCtD
Modafinil—Hypotension—Methylprednisolone—multiple sclerosis	0.000308	0.000747	CcSEcCtD
Modafinil—Pain—Prednisolone—multiple sclerosis	0.000307	0.000745	CcSEcCtD
Modafinil—Pharyngitis—Methotrexate—multiple sclerosis	0.000305	0.00074	CcSEcCtD
Modafinil—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000304	0.000736	CcSEcCtD
Modafinil—Urethral disorder—Methotrexate—multiple sclerosis	0.000301	0.00073	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000301	0.00073	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000301	0.000729	CcSEcCtD
Modafinil—Oedema—Betamethasone—multiple sclerosis	0.0003	0.000727	CcSEcCtD
Modafinil—Anaphylactic shock—Betamethasone—multiple sclerosis	0.0003	0.000727	CcSEcCtD
Modafinil—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.0003	0.000727	CcSEcCtD
Modafinil—Oedema—Dexamethasone—multiple sclerosis	0.0003	0.000727	CcSEcCtD
Modafinil—Diarrhoea—Mitoxantrone—multiple sclerosis	0.0003	0.000727	CcSEcCtD
Modafinil—Insomnia—Triamcinolone—multiple sclerosis	0.000299	0.000725	CcSEcCtD
Modafinil—Insomnia—Methylprednisolone—multiple sclerosis	0.000298	0.000723	CcSEcCtD
Modafinil—Infection—Betamethasone—multiple sclerosis	0.000298	0.000723	CcSEcCtD
Modafinil—Infection—Dexamethasone—multiple sclerosis	0.000298	0.000723	CcSEcCtD
Modafinil—Ill-defined disorder—Prednisone—multiple sclerosis	0.000297	0.00072	CcSEcCtD
Modafinil—Paraesthesia—Triamcinolone—multiple sclerosis	0.000297	0.00072	CcSEcCtD
Modafinil—Feeling abnormal—Prednisolone—multiple sclerosis	0.000296	0.000718	CcSEcCtD
Modafinil—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000296	0.000718	CcSEcCtD
Modafinil—Visual impairment—Methotrexate—multiple sclerosis	0.000296	0.000718	CcSEcCtD
Modafinil—Anaemia—Prednisone—multiple sclerosis	0.000296	0.000717	CcSEcCtD
Modafinil—Shock—Betamethasone—multiple sclerosis	0.000295	0.000716	CcSEcCtD
Modafinil—Shock—Dexamethasone—multiple sclerosis	0.000295	0.000716	CcSEcCtD
Modafinil—Dyspnoea—Triamcinolone—multiple sclerosis	0.000295	0.000715	CcSEcCtD
Modafinil—Nervous system disorder—Betamethasone—multiple sclerosis	0.000294	0.000713	CcSEcCtD
Modafinil—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000294	0.000713	CcSEcCtD
Modafinil—Agitation—Prednisone—multiple sclerosis	0.000294	0.000713	CcSEcCtD
Modafinil—Tachycardia—Betamethasone—multiple sclerosis	0.000293	0.00071	CcSEcCtD
Modafinil—Tachycardia—Dexamethasone—multiple sclerosis	0.000293	0.00071	CcSEcCtD
Modafinil—Angioedema—Prednisone—multiple sclerosis	0.000293	0.000709	CcSEcCtD
Modafinil—Dyspepsia—Triamcinolone—multiple sclerosis	0.000291	0.000706	CcSEcCtD
Modafinil—Erythema multiforme—Methotrexate—multiple sclerosis	0.000291	0.000705	CcSEcCtD
Modafinil—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00029	0.000704	CcSEcCtD
Modafinil—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00029	0.000703	CcSEcCtD
Modafinil—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00029	0.000703	CcSEcCtD
Modafinil—Malaise—Prednisone—multiple sclerosis	0.000289	0.0007	CcSEcCtD
Modafinil—Vertigo—Prednisone—multiple sclerosis	0.000288	0.000697	CcSEcCtD
Modafinil—Syncope—Prednisone—multiple sclerosis	0.000287	0.000696	CcSEcCtD
Modafinil—Anorexia—Dexamethasone—multiple sclerosis	0.000286	0.000693	CcSEcCtD
Modafinil—Anorexia—Betamethasone—multiple sclerosis	0.000286	0.000693	CcSEcCtD
Modafinil—Urticaria—Prednisolone—multiple sclerosis	0.000286	0.000692	CcSEcCtD
Modafinil—Cardiac disorder—Methotrexate—multiple sclerosis	0.000285	0.000692	CcSEcCtD
Modafinil—Fatigue—Triamcinolone—multiple sclerosis	0.000285	0.000691	CcSEcCtD
Modafinil—Fatigue—Methylprednisolone—multiple sclerosis	0.000284	0.00069	CcSEcCtD
Modafinil—Pain—Triamcinolone—multiple sclerosis	0.000283	0.000685	CcSEcCtD
Modafinil—Loss of consciousness—Prednisone—multiple sclerosis	0.000281	0.000682	CcSEcCtD
Modafinil—Fenoprofen—ALB—multiple sclerosis	0.00028	0.17	CrCbGaD
Modafinil—Hypotension—Dexamethasone—multiple sclerosis	0.00028	0.00068	CcSEcCtD
Modafinil—Hypotension—Betamethasone—multiple sclerosis	0.00028	0.00068	CcSEcCtD
Modafinil—Angiopathy—Methotrexate—multiple sclerosis	0.000279	0.000676	CcSEcCtD
Modafinil—Vomiting—Mitoxantrone—multiple sclerosis	0.000279	0.000676	CcSEcCtD
Modafinil—Immune system disorder—Methotrexate—multiple sclerosis	0.000278	0.000673	CcSEcCtD
Modafinil—Convulsion—Prednisone—multiple sclerosis	0.000277	0.000672	CcSEcCtD
Modafinil—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000277	0.000672	CcSEcCtD
Modafinil—Hypertension—Prednisone—multiple sclerosis	0.000276	0.00067	CcSEcCtD
Modafinil—Rash—Mitoxantrone—multiple sclerosis	0.000276	0.00067	CcSEcCtD
Modafinil—Dermatitis—Mitoxantrone—multiple sclerosis	0.000276	0.000669	CcSEcCtD
Modafinil—Chills—Methotrexate—multiple sclerosis	0.000276	0.000669	CcSEcCtD
Modafinil—Headache—Mitoxantrone—multiple sclerosis	0.000275	0.000666	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000273	0.000663	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000273	0.000663	CcSEcCtD
Modafinil—Arthralgia—Prednisone—multiple sclerosis	0.000273	0.000661	CcSEcCtD
Modafinil—Myalgia—Prednisone—multiple sclerosis	0.000273	0.000661	CcSEcCtD
Modafinil—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000272	0.000661	CcSEcCtD
Modafinil—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000272	0.000659	CcSEcCtD
Modafinil—Anxiety—Prednisone—multiple sclerosis	0.000272	0.000658	CcSEcCtD
Modafinil—Insomnia—Betamethasone—multiple sclerosis	0.000271	0.000658	CcSEcCtD
Modafinil—Insomnia—Dexamethasone—multiple sclerosis	0.000271	0.000658	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000271	0.000656	CcSEcCtD
Modafinil—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00027	0.000654	CcSEcCtD
Modafinil—Paraesthesia—Dexamethasone—multiple sclerosis	0.000269	0.000653	CcSEcCtD
Modafinil—Paraesthesia—Betamethasone—multiple sclerosis	0.000269	0.000653	CcSEcCtD
Modafinil—Discomfort—Prednisone—multiple sclerosis	0.000269	0.000653	CcSEcCtD
Modafinil—Mental disorder—Methotrexate—multiple sclerosis	0.000269	0.000653	CcSEcCtD
Modafinil—Malnutrition—Methotrexate—multiple sclerosis	0.000268	0.000649	CcSEcCtD
Modafinil—Hypersensitivity—Prednisolone—multiple sclerosis	0.000265	0.000642	CcSEcCtD
Modafinil—Dyspepsia—Dexamethasone—multiple sclerosis	0.000264	0.00064	CcSEcCtD
Modafinil—Dyspepsia—Betamethasone—multiple sclerosis	0.000264	0.00064	CcSEcCtD
Modafinil—Urticaria—Triamcinolone—multiple sclerosis	0.000263	0.000637	CcSEcCtD
Modafinil—Urticaria—Methylprednisolone—multiple sclerosis	0.000262	0.000635	CcSEcCtD
Modafinil—Dysgeusia—Methotrexate—multiple sclerosis	0.000262	0.000635	CcSEcCtD
Modafinil—Body temperature increased—Triamcinolone—multiple sclerosis	0.000261	0.000634	CcSEcCtD
Modafinil—Anaphylactic shock—Prednisone—multiple sclerosis	0.000261	0.000633	CcSEcCtD
Modafinil—Oedema—Prednisone—multiple sclerosis	0.000261	0.000633	CcSEcCtD
Modafinil—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000261	0.000632	CcSEcCtD
Modafinil—Decreased appetite—Dexamethasone—multiple sclerosis	0.000261	0.000632	CcSEcCtD
Modafinil—Decreased appetite—Betamethasone—multiple sclerosis	0.000261	0.000632	CcSEcCtD
Modafinil—Nausea—Mitoxantrone—multiple sclerosis	0.00026	0.000631	CcSEcCtD
Modafinil—Infection—Prednisone—multiple sclerosis	0.00026	0.000629	CcSEcCtD
Modafinil—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000259	0.000628	CcSEcCtD
Modafinil—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000259	0.000628	CcSEcCtD
Modafinil—Back pain—Methotrexate—multiple sclerosis	0.000259	0.000627	CcSEcCtD
Modafinil—Fatigue—Betamethasone—multiple sclerosis	0.000259	0.000627	CcSEcCtD
Modafinil—Fatigue—Dexamethasone—multiple sclerosis	0.000259	0.000627	CcSEcCtD
Modafinil—Shock—Prednisone—multiple sclerosis	0.000257	0.000623	CcSEcCtD
Modafinil—Pain—Betamethasone—multiple sclerosis	0.000257	0.000622	CcSEcCtD
Modafinil—Pain—Dexamethasone—multiple sclerosis	0.000257	0.000622	CcSEcCtD
Modafinil—Nervous system disorder—Prednisone—multiple sclerosis	0.000256	0.000621	CcSEcCtD
Modafinil—Tachycardia—Prednisone—multiple sclerosis	0.000255	0.000618	CcSEcCtD
Modafinil—Skin disorder—Prednisone—multiple sclerosis	0.000254	0.000615	CcSEcCtD
Modafinil—Hyperhidrosis—Prednisone—multiple sclerosis	0.000253	0.000612	CcSEcCtD
Modafinil—SLC6A3—Monoamine Transport—IL1B—multiple sclerosis	0.000249	0.00562	CbGpPWpGaD
Modafinil—Anorexia—Prednisone—multiple sclerosis	0.000249	0.000604	CcSEcCtD
Modafinil—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000248	0.000602	CcSEcCtD
Modafinil—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000248	0.00559	CbGpPWpGaD
Modafinil—Anaemia—Methotrexate—multiple sclerosis	0.000247	0.0006	CcSEcCtD
Modafinil—Feeling abnormal—Betamethasone—multiple sclerosis	0.000247	0.000599	CcSEcCtD
Modafinil—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000247	0.000599	CcSEcCtD
Modafinil—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000245	0.000595	CcSEcCtD
Modafinil—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000245	0.000595	CcSEcCtD
Modafinil—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000244	0.000591	CcSEcCtD
Modafinil—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000243	0.000589	CcSEcCtD
Modafinil—Phenprocoumon—ALB—multiple sclerosis	0.000242	0.147	CrCbGaD
Modafinil—Malaise—Methotrexate—multiple sclerosis	0.000241	0.000585	CcSEcCtD
Modafinil—Vertigo—Methotrexate—multiple sclerosis	0.00024	0.000583	CcSEcCtD
Modafinil—ADRA1B—G alpha (q) signalling events—GPR65—multiple sclerosis	0.00024	0.00541	CbGpPWpGaD
Modafinil—Urticaria—Dexamethasone—multiple sclerosis	0.000238	0.000578	CcSEcCtD
Modafinil—Urticaria—Betamethasone—multiple sclerosis	0.000238	0.000578	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000238	0.000577	CcSEcCtD
Modafinil—Dizziness—Prednisolone—multiple sclerosis	0.000238	0.000576	CcSEcCtD
Modafinil—Asthenia—Triamcinolone—multiple sclerosis	0.000237	0.000575	CcSEcCtD
Modafinil—Abdominal pain—Dexamethasone—multiple sclerosis	0.000237	0.000575	CcSEcCtD
Modafinil—Body temperature increased—Betamethasone—multiple sclerosis	0.000237	0.000575	CcSEcCtD
Modafinil—Abdominal pain—Betamethasone—multiple sclerosis	0.000237	0.000575	CcSEcCtD
Modafinil—Body temperature increased—Dexamethasone—multiple sclerosis	0.000237	0.000575	CcSEcCtD
Modafinil—Asthenia—Methylprednisolone—multiple sclerosis	0.000237	0.000574	CcSEcCtD
Modafinil—Insomnia—Prednisone—multiple sclerosis	0.000236	0.000573	CcSEcCtD
Modafinil—Oxcarbazepine—ALB—multiple sclerosis	0.000235	0.143	CrCbGaD
Modafinil—Paraesthesia—Prednisone—multiple sclerosis	0.000235	0.000569	CcSEcCtD
Modafinil—Pruritus—Triamcinolone—multiple sclerosis	0.000234	0.000567	CcSEcCtD
Modafinil—Cough—Methotrexate—multiple sclerosis	0.000233	0.000566	CcSEcCtD
Modafinil—Pruritus—Methylprednisolone—multiple sclerosis	0.000233	0.000566	CcSEcCtD
Modafinil—Convulsion—Methotrexate—multiple sclerosis	0.000232	0.000562	CcSEcCtD
Modafinil—Dyspepsia—Prednisone—multiple sclerosis	0.00023	0.000558	CcSEcCtD
Modafinil—Chest pain—Methotrexate—multiple sclerosis	0.000228	0.000552	CcSEcCtD
Modafinil—Arthralgia—Methotrexate—multiple sclerosis	0.000228	0.000552	CcSEcCtD
Modafinil—Myalgia—Methotrexate—multiple sclerosis	0.000228	0.000552	CcSEcCtD
Modafinil—SLC6A3—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000228	0.00514	CbGpPWpGaD
Modafinil—Decreased appetite—Prednisone—multiple sclerosis	0.000227	0.000551	CcSEcCtD
Modafinil—Rash—Prednisolone—multiple sclerosis	0.000227	0.00055	CcSEcCtD
Modafinil—Dermatitis—Prednisolone—multiple sclerosis	0.000226	0.000549	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000226	0.000548	CcSEcCtD
Modafinil—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000226	0.000547	CcSEcCtD
Modafinil—Fatigue—Prednisone—multiple sclerosis	0.000225	0.000546	CcSEcCtD
Modafinil—Headache—Prednisolone—multiple sclerosis	0.000225	0.000546	CcSEcCtD
Modafinil—Discomfort—Methotrexate—multiple sclerosis	0.000225	0.000546	CcSEcCtD
Modafinil—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000224	0.00505	CbGpPWpGaD
Modafinil—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000224	0.00505	CbGpPWpGaD
Modafinil—Constipation—Prednisone—multiple sclerosis	0.000223	0.000542	CcSEcCtD
Modafinil—Confusional state—Methotrexate—multiple sclerosis	0.00022	0.000534	CcSEcCtD
Modafinil—SLC6A3—Dopaminergic Neurogenesis—STAT3—multiple sclerosis	0.00022	0.00496	CbGpPWpGaD
Modafinil—Dizziness—Triamcinolone—multiple sclerosis	0.000219	0.00053	CcSEcCtD
Modafinil—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000218	0.000529	CcSEcCtD
Modafinil—Dizziness—Methylprednisolone—multiple sclerosis	0.000218	0.000529	CcSEcCtD
Modafinil—Infection—Methotrexate—multiple sclerosis	0.000217	0.000526	CcSEcCtD
Modafinil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000216	0.00487	CbGpPWpGaD
Modafinil—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000215	0.00486	CbGpPWpGaD
Modafinil—Feeling abnormal—Prednisone—multiple sclerosis	0.000215	0.000522	CcSEcCtD
Modafinil—Asthenia—Betamethasone—multiple sclerosis	0.000215	0.000522	CcSEcCtD
Modafinil—Asthenia—Dexamethasone—multiple sclerosis	0.000215	0.000522	CcSEcCtD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.000215	0.00484	CbGpPWpGaD
Modafinil—Warfarin—ALB—multiple sclerosis	0.000215	0.13	CrCbGaD
Modafinil—Nervous system disorder—Methotrexate—multiple sclerosis	0.000214	0.000519	CcSEcCtD
Modafinil—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000214	0.000518	CcSEcCtD
Modafinil—Nausea—Prednisolone—multiple sclerosis	0.000214	0.000518	CcSEcCtD
Modafinil—Pruritus—Betamethasone—multiple sclerosis	0.000212	0.000515	CcSEcCtD
Modafinil—Pruritus—Dexamethasone—multiple sclerosis	0.000212	0.000515	CcSEcCtD
Modafinil—Skin disorder—Methotrexate—multiple sclerosis	0.000212	0.000514	CcSEcCtD
Modafinil—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000211	0.000512	CcSEcCtD
Modafinil—Vomiting—Triamcinolone—multiple sclerosis	0.00021	0.00051	CcSEcCtD
Modafinil—Vomiting—Methylprednisolone—multiple sclerosis	0.00021	0.000509	CcSEcCtD
Modafinil—Rash—Triamcinolone—multiple sclerosis	0.000208	0.000505	CcSEcCtD
Modafinil—Dermatitis—Triamcinolone—multiple sclerosis	0.000208	0.000505	CcSEcCtD
Modafinil—Anorexia—Methotrexate—multiple sclerosis	0.000208	0.000505	CcSEcCtD
Modafinil—Rash—Methylprednisolone—multiple sclerosis	0.000208	0.000504	CcSEcCtD
Modafinil—Dermatitis—Methylprednisolone—multiple sclerosis	0.000208	0.000504	CcSEcCtD
Modafinil—Urticaria—Prednisone—multiple sclerosis	0.000208	0.000503	CcSEcCtD
Modafinil—Headache—Triamcinolone—multiple sclerosis	0.000207	0.000502	CcSEcCtD
Modafinil—Headache—Methylprednisolone—multiple sclerosis	0.000207	0.000501	CcSEcCtD
Modafinil—Abdominal pain—Prednisone—multiple sclerosis	0.000207	0.000501	CcSEcCtD
Modafinil—Body temperature increased—Prednisone—multiple sclerosis	0.000207	0.000501	CcSEcCtD
Modafinil—Diarrhoea—Dexamethasone—multiple sclerosis	0.000205	0.000498	CcSEcCtD
Modafinil—Diarrhoea—Betamethasone—multiple sclerosis	0.000205	0.000498	CcSEcCtD
Modafinil—Hypotension—Methotrexate—multiple sclerosis	0.000204	0.000495	CcSEcCtD
Modafinil—SLC6A3—Dopaminergic Neurogenesis—TGFB1—multiple sclerosis	0.000204	0.0046	CbGpPWpGaD
Modafinil—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000199	0.000482	CcSEcCtD
Modafinil—Dizziness—Betamethasone—multiple sclerosis	0.000198	0.000481	CcSEcCtD
Modafinil—Dizziness—Dexamethasone—multiple sclerosis	0.000198	0.000481	CcSEcCtD
Modafinil—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000198	0.00447	CbGpPWpGaD
Modafinil—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000198	0.00447	CbGpPWpGaD
Modafinil—Insomnia—Methotrexate—multiple sclerosis	0.000197	0.000479	CcSEcCtD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.000197	0.00445	CbGpPWpGaD
Modafinil—Nausea—Triamcinolone—multiple sclerosis	0.000196	0.000476	CcSEcCtD
Modafinil—Paraesthesia—Methotrexate—multiple sclerosis	0.000196	0.000475	CcSEcCtD
Modafinil—Nausea—Methylprednisolone—multiple sclerosis	0.000196	0.000475	CcSEcCtD
Modafinil—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000195	0.0044	CbGpPWpGaD
Modafinil—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000195	0.0044	CbGpPWpGaD
Modafinil—Dyspnoea—Methotrexate—multiple sclerosis	0.000195	0.000472	CcSEcCtD
Modafinil—Somnolence—Methotrexate—multiple sclerosis	0.000194	0.000471	CcSEcCtD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000193	0.00435	CbGpPWpGaD
Modafinil—Hypersensitivity—Prednisone—multiple sclerosis	0.000192	0.000467	CcSEcCtD
Modafinil—Dyspepsia—Methotrexate—multiple sclerosis	0.000192	0.000466	CcSEcCtD
Modafinil—Vomiting—Dexamethasone—multiple sclerosis	0.000191	0.000462	CcSEcCtD
Modafinil—Vomiting—Betamethasone—multiple sclerosis	0.000191	0.000462	CcSEcCtD
Modafinil—Decreased appetite—Methotrexate—multiple sclerosis	0.00019	0.00046	CcSEcCtD
Modafinil—Rash—Betamethasone—multiple sclerosis	0.000189	0.000459	CcSEcCtD
Modafinil—Rash—Dexamethasone—multiple sclerosis	0.000189	0.000459	CcSEcCtD
Modafinil—Dermatitis—Betamethasone—multiple sclerosis	0.000189	0.000458	CcSEcCtD
Modafinil—Dermatitis—Dexamethasone—multiple sclerosis	0.000189	0.000458	CcSEcCtD
Modafinil—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000189	0.000457	CcSEcCtD
Modafinil—Fatigue—Methotrexate—multiple sclerosis	0.000188	0.000456	CcSEcCtD
Modafinil—Headache—Betamethasone—multiple sclerosis	0.000188	0.000456	CcSEcCtD
Modafinil—Headache—Dexamethasone—multiple sclerosis	0.000188	0.000456	CcSEcCtD
Modafinil—Asthenia—Prednisone—multiple sclerosis	0.000187	0.000454	CcSEcCtD
Modafinil—Pain—Methotrexate—multiple sclerosis	0.000187	0.000453	CcSEcCtD
Modafinil—ADRA1B—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.000186	0.00418	CbGpPWpGaD
Modafinil—Pruritus—Prednisone—multiple sclerosis	0.000185	0.000448	CcSEcCtD
Modafinil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000185	0.00416	CbGpPWpGaD
Modafinil—SLC6A3—Monoamine Transport—TNF—multiple sclerosis	0.000181	0.00408	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000181	0.00407	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000181	0.00407	CbGpPWpGaD
Modafinil—Feeling abnormal—Methotrexate—multiple sclerosis	0.00018	0.000436	CcSEcCtD
Modafinil—Diarrhoea—Prednisone—multiple sclerosis	0.000179	0.000433	CcSEcCtD
Modafinil—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000179	0.000433	CcSEcCtD
Modafinil—Nausea—Betamethasone—multiple sclerosis	0.000178	0.000432	CcSEcCtD
Modafinil—Nausea—Dexamethasone—multiple sclerosis	0.000178	0.000432	CcSEcCtD
Modafinil—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000178	0.00402	CbGpPWpGaD
Modafinil—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000178	0.00402	CbGpPWpGaD
Modafinil—Urticaria—Methotrexate—multiple sclerosis	0.000173	0.000421	CcSEcCtD
Modafinil—Dizziness—Prednisone—multiple sclerosis	0.000173	0.000419	CcSEcCtD
Modafinil—Body temperature increased—Methotrexate—multiple sclerosis	0.000173	0.000418	CcSEcCtD
Modafinil—Abdominal pain—Methotrexate—multiple sclerosis	0.000173	0.000418	CcSEcCtD
Modafinil—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.00017	0.00384	CbGpPWpGaD
Modafinil—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.00017	0.00383	CbGpPWpGaD
Modafinil—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000168	0.00378	CbGpPWpGaD
Modafinil—Vomiting—Prednisone—multiple sclerosis	0.000166	0.000403	CcSEcCtD
Modafinil—Ketoprofen—ALB—multiple sclerosis	0.000166	0.101	CrCbGaD
Modafinil—Rash—Prednisone—multiple sclerosis	0.000165	0.000399	CcSEcCtD
Modafinil—Dermatitis—Prednisone—multiple sclerosis	0.000165	0.000399	CcSEcCtD
Modafinil—Headache—Prednisone—multiple sclerosis	0.000164	0.000397	CcSEcCtD
Modafinil—Hypersensitivity—Methotrexate—multiple sclerosis	0.000161	0.00039	CcSEcCtD
Modafinil—SLC6A3—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000159	0.00359	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000159	0.00358	CbGpPWpGaD
Modafinil—Asthenia—Methotrexate—multiple sclerosis	0.000157	0.00038	CcSEcCtD
Modafinil—Phenytoin—ALB—multiple sclerosis	0.000156	0.0946	CrCbGaD
Modafinil—Nausea—Prednisone—multiple sclerosis	0.000155	0.000376	CcSEcCtD
Modafinil—Pruritus—Methotrexate—multiple sclerosis	0.000154	0.000375	CcSEcCtD
Modafinil—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000154	0.00348	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000154	0.00348	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000153	0.00344	CbGpPWpGaD
Modafinil—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000152	0.00343	CbGpPWpGaD
Modafinil—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000152	0.00343	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—S1PR1—multiple sclerosis	0.00015	0.00339	CbGpPWpGaD
Modafinil—SLC6A3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.00015	0.00338	CbGpPWpGaD
Modafinil—Diarrhoea—Methotrexate—multiple sclerosis	0.000149	0.000362	CcSEcCtD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.000145	0.00328	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.000145	0.00328	CbGpPWpGaD
Modafinil—Dizziness—Methotrexate—multiple sclerosis	0.000144	0.00035	CcSEcCtD
Modafinil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000142	0.00321	CbGpPWpGaD
Modafinil—Vomiting—Methotrexate—multiple sclerosis	0.000139	0.000337	CcSEcCtD
Modafinil—Rash—Methotrexate—multiple sclerosis	0.000138	0.000334	CcSEcCtD
Modafinil—Dermatitis—Methotrexate—multiple sclerosis	0.000138	0.000333	CcSEcCtD
Modafinil—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000137	0.00309	CbGpPWpGaD
Modafinil—Headache—Methotrexate—multiple sclerosis	0.000137	0.000332	CcSEcCtD
Modafinil—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000134	0.00302	CbGpPWpGaD
Modafinil—Nausea—Methotrexate—multiple sclerosis	0.00013	0.000314	CcSEcCtD
Modafinil—ADRA1B—GPCR ligand binding—GPR65—multiple sclerosis	0.000121	0.00273	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000119	0.00269	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000119	0.00269	CbGpPWpGaD
Modafinil—ADRA1B—LPA receptor mediated events—MMP9—multiple sclerosis	0.000118	0.00265	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000117	0.00265	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000117	0.00265	CbGpPWpGaD
Modafinil—ADRA1B—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000116	0.00262	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000116	0.00261	CbGpPWpGaD
Modafinil—SLC6A3—Neuronal System—BCHE—multiple sclerosis	0.000115	0.00259	CbGpPWpGaD
Modafinil—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000112	0.00253	CbGpPWpGaD
Modafinil—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000111	0.0025	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—CXCL13—multiple sclerosis	0.000111	0.0025	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—CCR1—multiple sclerosis	0.000111	0.0025	CbGpPWpGaD
Modafinil—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000109	0.00247	CbGpPWpGaD
Modafinil—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000108	0.00245	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000104	0.00234	CbGpPWpGaD
Modafinil—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000103	0.00233	CbGpPWpGaD
Modafinil—ADRA1B—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.000101	0.00228	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	9.97e-05	0.00225	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	9.63e-05	0.00217	CbGpPWpGaD
Modafinil—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.43e-05	0.00213	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	9.37e-05	0.00211	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.15e-05	0.00206	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	8.65e-05	0.00195	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—S1PR1—multiple sclerosis	8.49e-05	0.00191	CbGpPWpGaD
Modafinil—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.38e-05	0.00189	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	8.29e-05	0.00187	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.09e-05	0.00182	CbGpPWpGaD
Modafinil—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.06e-05	0.00182	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—CCL3—multiple sclerosis	7.89e-05	0.00178	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	7.79e-05	0.00176	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—S1PR1—multiple sclerosis	7.71e-05	0.00174	CbGpPWpGaD
Modafinil—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.65e-05	0.00172	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.6e-05	0.00171	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.6e-05	0.00171	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—PTGER4—multiple sclerosis	7.59e-05	0.00171	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	7.4e-05	0.00167	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	7.37e-05	0.00166	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—CXCR3—multiple sclerosis	7.33e-05	0.00165	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—RGS1—multiple sclerosis	7.22e-05	0.00163	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—CCR2—multiple sclerosis	7.13e-05	0.00161	CbGpPWpGaD
Modafinil—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	7.05e-05	0.00159	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.93e-05	0.00156	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.93e-05	0.00156	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—GPR65—multiple sclerosis	6.84e-05	0.00154	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	6.7e-05	0.00151	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—CNR1—multiple sclerosis	6.58e-05	0.00148	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—RGS1—multiple sclerosis	6.55e-05	0.00148	CbGpPWpGaD
Modafinil—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.53e-05	0.00147	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—SRM—multiple sclerosis	6.36e-05	0.00143	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CCR1—multiple sclerosis	6.26e-05	0.00141	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CXCL13—multiple sclerosis	6.26e-05	0.00141	CbGpPWpGaD
Modafinil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.22e-05	0.0014	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—SRM—multiple sclerosis	6.22e-05	0.0014	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—GPR65—multiple sclerosis	6.21e-05	0.0014	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	6.04e-05	0.00136	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—LINGO1—multiple sclerosis	6.01e-05	0.00135	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—CXCL10—multiple sclerosis	5.93e-05	0.00134	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.92e-05	0.00134	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.92e-05	0.00134	CbGpPWpGaD
Modafinil—CYP2B6—Biological oxidations—POMC—multiple sclerosis	5.89e-05	0.00133	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	5.76e-05	0.0013	CbGpPWpGaD
Modafinil—CYP3A5—Biological oxidations—POMC—multiple sclerosis	5.76e-05	0.0013	CbGpPWpGaD
Modafinil—SLC6A3—NRF2 pathway—TGFB1—multiple sclerosis	5.75e-05	0.0013	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	5.75e-05	0.0013	CbGpPWpGaD
Modafinil—SLC6A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	5.73e-05	0.00129	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CXCL13—multiple sclerosis	5.68e-05	0.00128	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CCR1—multiple sclerosis	5.68e-05	0.00128	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	5.66e-05	0.00128	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	5.64e-05	0.00127	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	5.37e-05	0.00121	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	5.37e-05	0.00121	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TAGAP—multiple sclerosis	5.21e-05	0.00117	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—CCL5—multiple sclerosis	5.1e-05	0.00115	CbGpPWpGaD
Modafinil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.04e-05	0.00114	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—SRM—multiple sclerosis	4.81e-05	0.00108	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	4.72e-05	0.00106	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	4.62e-05	0.00104	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—CCR5—multiple sclerosis	4.6e-05	0.00104	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—S1PR1—multiple sclerosis	4.55e-05	0.00103	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	4.48e-05	0.00101	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	4.48e-05	0.00101	CbGpPWpGaD
Modafinil—CYP2C19—Biological oxidations—POMC—multiple sclerosis	4.45e-05	0.001	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—GPC5—multiple sclerosis	4.43e-05	0.000999	CbGpPWpGaD
Modafinil—SLC6A3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.38e-05	0.000989	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SRM—multiple sclerosis	4.38e-05	0.000988	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	4.38e-05	0.000988	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	4.38e-05	0.000988	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PTGER4—multiple sclerosis	4.29e-05	0.000968	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CXCR3—multiple sclerosis	4.14e-05	0.000935	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GPC5—multiple sclerosis	4.1e-05	0.000924	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—POMC—multiple sclerosis	4.06e-05	0.000916	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CCL3—multiple sclerosis	4.05e-05	0.000913	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CCR2—multiple sclerosis	4.03e-05	0.000909	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GPC5—multiple sclerosis	4.01e-05	0.000903	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PTGER4—multiple sclerosis	3.9e-05	0.000879	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RGS1—multiple sclerosis	3.87e-05	0.000873	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CXCR3—multiple sclerosis	3.76e-05	0.000849	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SRM—multiple sclerosis	3.74e-05	0.000844	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CNR1—multiple sclerosis	3.72e-05	0.000839	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—GPR65—multiple sclerosis	3.67e-05	0.000828	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CCR2—multiple sclerosis	3.66e-05	0.000826	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	3.6e-05	0.000813	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—POMC—multiple sclerosis	3.59e-05	0.00081	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—CCL2—multiple sclerosis	3.52e-05	0.000793	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—POMC—multiple sclerosis	3.47e-05	0.000783	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—RRM1—multiple sclerosis	3.4e-05	0.000766	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.39e-05	0.000764	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.39e-05	0.000764	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CNR1—multiple sclerosis	3.38e-05	0.000762	CbGpPWpGaD
Modafinil—SLC6A3—Neuronal System—MAPK1—multiple sclerosis	3.36e-05	0.000757	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CXCL13—multiple sclerosis	3.36e-05	0.000757	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCR1—multiple sclerosis	3.36e-05	0.000757	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CXCL10—multiple sclerosis	3.35e-05	0.000755	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—RRM1—multiple sclerosis	3.32e-05	0.000749	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.31e-05	0.000746	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.1e-05	0.000698	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	3.09e-05	0.000696	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	3.09e-05	0.000696	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CXCL10—multiple sclerosis	3.04e-05	0.000686	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.02e-05	0.00068	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.91e-05	0.000657	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SRM—multiple sclerosis	2.89e-05	0.000652	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CCL5—multiple sclerosis	2.88e-05	0.00065	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.82e-05	0.000637	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	2.77e-05	0.000624	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.68e-05	0.000604	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.64e-05	0.000595	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.64e-05	0.000595	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CCL5—multiple sclerosis	2.62e-05	0.000591	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CCR5—multiple sclerosis	2.6e-05	0.000586	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.58e-05	0.000582	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.57e-05	0.000579	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—IL2RA—multiple sclerosis	2.56e-05	0.000577	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.41e-05	0.000544	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCL3—multiple sclerosis	2.39e-05	0.000539	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CCR5—multiple sclerosis	2.36e-05	0.000532	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.34e-05	0.000528	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL2RA—multiple sclerosis	2.33e-05	0.000524	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PTGER4—multiple sclerosis	2.3e-05	0.000519	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PGR—multiple sclerosis	2.27e-05	0.000511	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CXCR3—multiple sclerosis	2.22e-05	0.000501	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CD28—multiple sclerosis	2.2e-05	0.000497	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCR2—multiple sclerosis	2.16e-05	0.000488	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.04e-05	0.000459	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.04e-05	0.000459	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—POMC—multiple sclerosis	2.03e-05	0.000458	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—RRM1—multiple sclerosis	2e-05	0.000451	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CNR1—multiple sclerosis	2e-05	0.00045	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.99e-05	0.000449	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.95e-05	0.00044	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.91e-05	0.00043	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.86e-05	0.00042	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—POMC—multiple sclerosis	1.84e-05	0.000416	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.82e-05	0.000409	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CCL2—multiple sclerosis	1.8e-05	0.000407	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CXCL10—multiple sclerosis	1.8e-05	0.000405	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.71e-05	0.000386	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—TYK2—multiple sclerosis	1.64e-05	0.000369	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CD86—multiple sclerosis	1.57e-05	0.000354	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.56e-05	0.000352	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.56e-05	0.000352	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.55e-05	0.00035	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCL5—multiple sclerosis	1.55e-05	0.000349	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.54e-05	0.000348	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	1.5e-05	0.000339	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.47e-05	0.000332	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	1.43e-05	0.000323	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.42e-05	0.000321	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	1.39e-05	0.000314	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	1.37e-05	0.00031	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	1.36e-05	0.000307	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.34e-05	0.000303	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.33e-05	0.000301	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	1.27e-05	0.000286	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.22e-05	0.000274	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—APOE—multiple sclerosis	1.17e-05	0.000265	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.15e-05	0.000259	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—APOE—multiple sclerosis	1.15e-05	0.000259	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	1.15e-05	0.000259	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	1.09e-05	0.000246	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	1.07e-05	0.00024	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	1.04e-05	0.000235	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—POMC—multiple sclerosis	1.01e-05	0.000227	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—POMC—multiple sclerosis	9.85e-06	0.000222	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	9.68e-06	0.000218	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ALB—multiple sclerosis	9.19e-06	0.000207	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ALB—multiple sclerosis	8.98e-06	0.000203	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—APOE—multiple sclerosis	8.87e-06	0.0002	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—BCHE—multiple sclerosis	8.86e-06	0.0002	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—APOE—multiple sclerosis	8.08e-06	0.000182	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	8.05e-06	0.000182	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	8.01e-06	0.000181	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	7.62e-06	0.000172	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—POMC—multiple sclerosis	7.62e-06	0.000172	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—POMC—multiple sclerosis	6.95e-06	0.000157	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ALB—multiple sclerosis	6.94e-06	0.000157	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—APOE—multiple sclerosis	6.91e-06	0.000156	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	6.78e-06	0.000153	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ALB—multiple sclerosis	6.33e-06	0.000143	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	6.3e-06	0.000142	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	6.28e-06	0.000142	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	6.16e-06	0.000139	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—POMC—multiple sclerosis	5.94e-06	0.000134	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALB—multiple sclerosis	5.41e-06	0.000122	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APOE—multiple sclerosis	5.33e-06	0.00012	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	4.73e-06	0.000107	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—POMC—multiple sclerosis	4.58e-06	0.000103	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALB—multiple sclerosis	4.18e-06	9.42e-05	CbGpPWpGaD
